GF
SUPN icon

Gabelli Funds’s Supernus Pharmaceuticals SUPN Stock Holding History

Gabelli Funds’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Hold
23,000
– – 0.01% 909
2026
Q1 		$1.19M Hold
23,000
– – 0.01% 863
2025
Q4 		$1.14M Buy
23,000
+5,410
+31% +$263K 0.01% 872
2025
Q3 		$841K Hold
17,590
– – 0.01% 950
2025
Q2 		$554K Buy
+17,590
New +$564K ﹤0.01% 1006

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Gabelli Funds's SUPN Position: Q2 2026 in Review

Gabelli Funds held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 23,000 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #909.

Gabelli Funds first reported a position in SUPN in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.19M in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Gabelli Funds held 23,000 shares of Supernus Pharmaceuticals worth $1.07M as of Q2 2026.
  • Gabelli Funds left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #909 holding.
  • Gabelli Funds first reported a position in Supernus Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Gabelli Funds's Supernus Pharmaceuticals position peaked at $1.19M in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.